| Adherence N (%) | Non-adherence N (%) | p-value** |
---|---|---|---|
Study intervention arm | Â | Â | 0.019 |
Supervised (N = 184) | 131 (71.2) | 53 (28.8) |  |
Unsupervised (N = 160) | 91 (56.9) | 69 (43.1) |  |
Control (N = 263) | 164 (62.4) | 99 (37.6) |  |
Malaria species at trial enrolment | Â | Â | 0.084 |
P. vivax single/mix (N = 260) | 179 (68.8) | 81 (31.2) |  |
P. falciparum (N = 307) | 182 (59.3) | 125 (40.7) |  |
Other species (N = 2) | 1 (50) | 1 (50) |  |
Species details not available (N = 38) | 24 (63.2) | 14 (36.8) |  |
Group of ethnicities |  |  | < 0.001 |
Highland Papuans (N = 99) | 47 (47.5) | 52 (52.5) |  |
Lowland Papuans (N = 147) | 76 (51.7) | 71 (48.3) |  |
Non-Papuans (N = 361) | 263 (72.9) | 98 (27.1) |  |
Time between trial enrolment and survey | Â | Â | 0.417 |
Before/at 6-month follow-up (N = 195) | 129 (66.2) | 66 (33.9) |  |
After 6-month follow-up (N = 412) | 257 (62.4) | 155 (37.6) |  |